DNA (Cytosine-5-)-Methyltransferases
"DNA (Cytosine-5-)-Methyltransferases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that catalyzes the transfer of a methyl group from S-ADENOSYLMETHIONINE to the 5-position of CYTOSINE residues in DNA.
Descriptor ID |
D004248
|
MeSH Number(s) |
D08.811.913.555.500.350.100.500
|
Concept/Terms |
DNA (Cytosine-5-)-Methyltransferases- DNA (Cytosine-5-)-Methyltransferases
- DNA (Cytosine-5-)-Methyltransferase
- DNA Cytosine-5-Methylase
- Cytosine-5-Methylase, DNA
- DNA Cytosine 5 Methylase
- DNA (Cytosine 5) Methyltransferase
|
Below are MeSH descriptors whose meaning is more general than "DNA (Cytosine-5-)-Methyltransferases".
Below are MeSH descriptors whose meaning is more specific than "DNA (Cytosine-5-)-Methyltransferases".
This graph shows the total number of publications written about "DNA (Cytosine-5-)-Methyltransferases" by people in this website by year, and whether "DNA (Cytosine-5-)-Methyltransferases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2002 | 2 | 2 | 4 |
2003 | 3 | 3 | 6 |
2004 | 3 | 1 | 4 |
2005 | 2 | 1 | 3 |
2006 | 5 | 5 | 10 |
2007 | 5 | 4 | 9 |
2008 | 8 | 4 | 12 |
2009 | 4 | 5 | 9 |
2010 | 3 | 5 | 8 |
2011 | 5 | 2 | 7 |
2012 | 2 | 6 | 8 |
2013 | 5 | 3 | 8 |
2014 | 5 | 2 | 7 |
2015 | 6 | 4 | 10 |
2016 | 4 | 2 | 6 |
2017 | 6 | 2 | 8 |
2018 | 5 | 2 | 7 |
2019 | 3 | 5 | 8 |
2020 | 7 | 2 | 9 |
2021 | 1 | 0 | 1 |
2022 | 4 | 2 | 6 |
2023 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA (Cytosine-5-)-Methyltransferases" by people in Profiles.
-
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential. Blood Adv. 2023 04 11; 7(7):1308-1311.
-
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells. Nat Cell Biol. 2023 04; 25(4):528-539.
-
Mediating and maintaining methylation while minimizing mutation: Recent advances on mammalian DNA methyltransferases. Curr Opin Struct Biol. 2022 08; 75:102433.
-
First-in-Class Allosteric Inhibitors of DNMT3A Disrupt Protein-Protein Interactions and Induce Acute Myeloid Leukemia Cell Differentiation. J Med Chem. 2022 08 11; 65(15):10554-10566.
-
Constitutive loss of DNMT3A causes morbid obesity through misregulation of adipogenesis. Elife. 2022 05 30; 11.
-
Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21. Blood Cancer Discov. 2022 05 05; 3(3):220-239.
-
Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors. Structure. 2022 06 02; 30(6):793-802.e5.
-
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome. Haematologica. 2022 04 01; 107(4):887-898.
-
Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFN? signaling. Cell Stem Cell. 2021 08 05; 28(8):1428-1442.e6.
-
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice. Leukemia. 2021 07; 35(7):1949-1963.